Discovery of Immune Defense Mechanism Could Help Improve Treatments
Scientists have made a fundamental discovery about how our body's immune system clears harmful infections.
Researchers have identified a previously unknown mechanism by which the responses of key cells of the immune system are regulated.
The finding could inform research into improved treatments for allergies or chronic inflammatory diseases, such as lung and liver fibrosis, researchers say.
Scientists at the University of Edinburgh made the discovery by studying how the immune system in mice fights off parasitic worms. These parasites provoke a strong immune response, enabling researchers to carry out in-depth studies of the defence mechanisms involved.
They found that chemical signals from infecting organisms activate cells - called Th2 cells - causing them to multiply and express a key protein, known as EGFR.
The cells then migrate from the lymph nodes - where they are stored - to the site of infection, where they release defence proteins to expel the parasites.
Researchers found that Th2 cells release defence molecules when they detect the damage caused by invading parasites, but can only perform this task if they express EGFR.
This safety mechanism - unknown until now - blocks the release of defence molecules in the absence of parasites, and thereby prevents tissue damage, the team says.
The study, published in the journal Immunity, was funded by the Medical Research Council, European Union and Austrian Science Fund. It was carried out in collaboration with other scientists from the UK, Germany, Ireland, Austria and The Netherlands.
Dr Dietmar Zaiss, of the University of Edinburgh's School of Biological Sciences, who led the study, said: "We found an entirely new mechanism by which immune responses against parasites are regulated. These findings give us fresh insight into the functioning of local immune responses and should allow us to develop better vaccines against parasite infections."
This article has been republished from materials provided by The University of Edinburgh. Note: material may have been edited for length and content. For further information, please contact the cited source.
Agent Reverses Resistance to Targeted Drug in Some LeukemiasNews
After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.READ MORE
Blueprints for Anti-cancer Drugs Identified in Bacterial GenomesNews
Scientists have now brought the family of LNM molecules even closer to clinical testing by “mining” the information stored in bacteria genomes. Their research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.READ MORE
Uptake of Controlled Release Drug Delivery Technology Set to Increase?News
The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.READ MORE